{
    "title": "Generating synthetic multi-dimensional molecular-mediator time series data for artificial intelligence-based disease trajectory forecasting and drug development digital twins: Considerations. (arXiv:2303.09056v1 [cs.AI])",
    "abstract": "The use of synthetic data is recognized as a crucial step in the development of neural network-based Artificial Intelligence (AI) systems. While the methods for generating synthetic data for AI applications in other domains have a role in certain biomedical AI systems, primarily related to image processing, there is a critical gap in the generation of time series data for AI tasks where it is necessary to know how the system works. This is most pronounced in the ability to generate synthetic multi-dimensional molecular time series data (SMMTSD); this is the type of data that underpins research into biomarkers and mediator signatures for forecasting various diseases and is an essential component of the drug development pipeline. We argue the insufficiency of statistical and data-centric machine learning (ML) means of generating this type of synthetic data is due to a combination of factors: perpetual data sparsity due to the Curse of Dimensionality, the inapplicability of the Central Li",
    "link": "http://arxiv.org/abs/2303.09056",
    "context": "Title: Generating synthetic multi-dimensional molecular-mediator time series data for artificial intelligence-based disease trajectory forecasting and drug development digital twins: Considerations. (arXiv:2303.09056v1 [cs.AI])\nAbstract: The use of synthetic data is recognized as a crucial step in the development of neural network-based Artificial Intelligence (AI) systems. While the methods for generating synthetic data for AI applications in other domains have a role in certain biomedical AI systems, primarily related to image processing, there is a critical gap in the generation of time series data for AI tasks where it is necessary to know how the system works. This is most pronounced in the ability to generate synthetic multi-dimensional molecular time series data (SMMTSD); this is the type of data that underpins research into biomarkers and mediator signatures for forecasting various diseases and is an essential component of the drug development pipeline. We argue the insufficiency of statistical and data-centric machine learning (ML) means of generating this type of synthetic data is due to a combination of factors: perpetual data sparsity due to the Curse of Dimensionality, the inapplicability of the Central Li",
    "path": "papers/23/03/2303.09056.json",
    "total_tokens": 928,
    "translated_title": "生成多维分子介质时间序列数据用于基于人工智能的疾病轨迹预测和药物开发数字孪生：考虑因素",
    "translated_abstract": "合成数据的使用被认为是神经网络人工智能系统开发中的一个关键步骤。虽然生成用于其他领域人工智能应用程序的合成数据的方法在特定的生物医学人工智能系统中具有作用，主要涉及图像处理。但在需要了解系统工作的人工智能任务的时间序列数据的生成中存在明显的差距。最为突出的是在生成多维分子时间序列数据方面存在困难，这是预测各种疾病的生物标记和介质特征研究的基础数据，并且是药物研发流程的核心组成部分。我们认为，由于维度灾难导致数据稀疏不足以及统计和数据中心机器学习（ML）的不适用性，这种类型的合成数据生成存在不足。",
    "tldr": "研究发现，在生成多维分子介质时间序列数据方面存在巨大的困难，这种类型的数据对于预测疾病轨迹和药物研发具有重要意义，现有的统计和数据中心机器学习方法无法解决数据稀缺和维度灾难的问题。",
    "en_tdlr": "The generation of multi-dimensional molecular mediator time series data is crucial for disease trajectory forecasting and drug development, and the current statistical and data-centric machine learning methods are insufficient due to the Curse of Dimensionality and perpetual data sparsity."
}